Kiyose, Japan

Takashi Naka

This inventor holds 1 USPTO granted patent. Top assignees: Japan Bcg Laboratory, Riken Corporation. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Naka. Retrieved from https://idiyas.com/inventor/takashi-naka-7uk8ru2i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takashi Naka: Innovator in Immunology

Introduction

Takashi Naka is a prominent inventor based in Kiyose, Japan. He is known for his significant contributions to the field of immunology, particularly in the differentiation of T-helper cells. His innovative work has implications for cancer therapy and the treatment of allergic diseases.

Latest Patents

Naka holds a patent for a Th1 cell differentiation accelerator. This invention provides an agent for promoting human Th1 cell differentiation and suppressing human Th2 cell differentiation. The agent comprises lipoarabinomannans and/or lipomannans derived from BCG cell bodies. It is useful as a prophylactic and therapeutic agent for cancers and as a treatment for allergic diseases such as pollinosis. He has 1 patent to his name.

Career Highlights

Throughout his career, Takashi Naka has worked with notable organizations, including Riken Corporation and Japan BCG Laboratory. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Naka has collaborated with esteemed colleagues, including Masaru Taniguchi and Toshinori Nakayama. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Takashi Naka's innovative contributions to immunology highlight his role as a key inventor in the field. His work continues to influence therapeutic approaches for various diseases, showcasing the importance of research and innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…